Filing Analysis
Asset Acquisition
Filed May 06, 2026
MEDIUM
908 Devices Inc. acquired Swiss-based NIRLAB SA for a headline price of $15 million, consisting of $13 million in cash and 293,368 shares of common stock. The deal includes a potential $8 million revenue-based earn-out through 2027 and coincided with the company's Q1 2026 financial results announcement.
Key Facts
- Acquisition of NIRLAB SA and its subsidiary NIRLAB Forensics Sàrl completed on May 4, 2026.
- Upfront consideration of $15,000,000 comprised of $13,000,000 in cash and 293,368 shares of common stock.
- Potential earn-out consideration of up to $8,000,000 in shares based on revenue milestones through December 31, 2027.
- Stock consideration was subject to a contractual floor price of $5.88 per share.
- A general holdback of $1.3 million cash and 10% of stock consideration is in place for 12 months to secure indemnity obligations.
- Sellers are subject to a 180-day lock-up period and a 3-year non-compete agreement.
Regulation FD Disclosure
Filed Mar 03, 2026
LOW
908 Devices Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. The company also released an updated investor presentation on its corporate website.
Key Facts
- Financial results for Q4 and FY 2025 were reported on March 3, 2026
- Press release furnished as Exhibit 99.1
- Updated investor presentation posted to the 'Events & Presentations' section of the company website
- The filing was made under Item 2.02 (Results of Operations and Financial Condition)
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.